Literature DB >> 204899

The role of antibiotics, immunizations, and adenoviruses in pertussis.

L J Baraff, J Wilkins, P F Wehrle.   

Abstract

Sixty-five patients with pertussis were identified by a clinical criterion, and Bordetella pertussis was isolated from 75% of these patients or their symptomatic household contacts. Negative nasopharyngeal cultures were usually associated with either a history of antibiotic therapy with erythromycin or tetracycline (two of three patients), two or more diphtheria and tetanus toxoids with pertussis (DTP) vaccines (six of eight patients), or both (two of three patients). Erythromycin therapy resulted in the elimination of B. pertussis from the nasopharynx in 2 to 7 days (mean, 3.6 days) compared with 7 to 17 or more days (mean, greater than 12 days) in patients treated with no antibiotics, but had no effect on the duration or severity of illness as judged by length of hospitalization. Adenoviruses were recovered from five of 44 patients cultured. Four of these isolates were from throat swabs obtained early in the illness and the remaining isolate was from one of 33 repeated viral cultures obtained two to three weeks later; B. pertussis was also isolated from these five patients. Paired serum samples were obtained from only two of these patients. Neither demonstrated a fourfold rise in adenoviral complement-fixing antibodies. Therefore, in these patients, adenoviral isolation may have been secondary to reactivation of a latent viral infection by infection with B. pertussis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 204899

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  19 in total

Review 1.  Pertussis: the disease and new diagnostic methods.

Authors:  R L Friedman
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

Review 2.  Laboratory diagnosis of pertussis: state of the art in 1997.

Authors:  F M Müller; J E Hoppe; C H Wirsing von König
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

Review 3.  Treatment and prevention of pertussis by antimicrobial agents (Part II).

Authors:  J E Hoppe; A Haug
Journal:  Infection       Date:  1988 May-Jun       Impact factor: 3.553

4.  Development of a rapid diagnostic test for pertussis: direct detection of pertussis toxin in respiratory secretions.

Authors:  R L Friedman; S Paulaitis; J W McMillan
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

Review 5.  Common bacterial infections in infancy and childhood. 1. Respiratory infections.

Authors:  H C Spratt; G A Ahronheim; M I Marks
Journal:  Drugs       Date:  1978-08       Impact factor: 9.546

6.  The severity of whooping cough in hospitalised children--is it declining?

Authors:  I D Johnston; H R Anderson; H P Lambert
Journal:  J Hyg (Lond)       Date:  1985-04

Review 7.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

8.  Multiplex PCR-based assay for detection of Bordetella pertussis in nasopharyngeal swab specimens.

Authors:  R M Wadowsky; R H Michaels; T Libert; L A Kingsley; G D Ehrlich
Journal:  J Clin Microbiol       Date:  1996-11       Impact factor: 5.948

9.  Nested duplex PCR to detect Bordetella pertussis and Bordetella parapertussis and its application in diagnosis of pertussis in nonmetropolitan Southeast Queensland, Australia.

Authors:  D J Farrell; G Daggard; T K Mukkur
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  Enzyme-linked immunosorbent assay for detection of pertussis immunoglobulin A in nasopharyngeal secretions as an indicator of recent infection.

Authors:  Y E Goodman; A J Wort; F L Jackson
Journal:  J Clin Microbiol       Date:  1981-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.